Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,292 | 282 | 99.5% |
| Education | $29.03 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,207 | 100 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,308 | 70 | $0 (2024) |
| Janssen Biotech, Inc. | $499.11 | 20 | $0 (2024) |
| Celgene Corporation | $274.76 | 16 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $251.75 | 11 | $0 (2023) |
| Intuitive Surgical, Inc. | $193.03 | 1 | $0 (2021) |
| Merck Sharp & Dohme LLC | $192.95 | 9 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $123.50 | 7 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $120.89 | 6 | $0 (2023) |
| HISTOSONICS,INC. | $117.38 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,513 | 59 | ABBVIE INC. ($600.89) |
| 2023 | $1,284 | 54 | AbbVie Inc. ($383.13) |
| 2022 | $1,526 | 75 | ABBVIE INC. ($665.33) |
| 2021 | $1,692 | 83 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($552.76) |
| 2020 | $273.85 | 13 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($104.31) |
| 2019 | $31.64 | 1 | Boston Scientific Corporation ($31.64) |
All Payment Transactions
285 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $32.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: Immunology | ||||||
| 10/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: Immunology | ||||||
| 09/03/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Education | In-kind items and services | $8.45 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | HISTOSONICS,INC. | — | Food and Beverage | Cash or cash equivalent | $117.38 | General |
| 08/21/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.02 | General |
| Category: GI | ||||||
| 08/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: GI | ||||||
| 08/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/06/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: Immunology | ||||||
| 08/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 612 | 784 | $561,681 | $95,818 |
| 2022 | 9 | 436 | 599 | $420,589 | $71,938 |
| 2021 | 12 | 399 | 505 | $325,643 | $54,607 |
| 2020 | 1 | 11 | 11 | $8,987 | $1,755 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 153 | 240 | $207,360 | $37,090 | 17.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 74 | 146 | $54,166 | $9,767 | 18.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 87 | 90 | $58,140 | $7,764 | 13.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 36 | 36 | $37,980 | $6,658 | 17.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $32,841 | $5,958 | 18.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 41 | 45 | $27,405 | $4,782 | 17.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 40 | 40 | $37,360 | $4,345 | 11.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 18 | 18 | $21,240 | $3,279 | 15.4% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 11 | 11 | $16,973 | $3,277 | 19.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 28 | $15,624 | $2,814 | 18.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 14 | 14 | $12,040 | $2,603 | 21.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 13 | 13 | $11,167 | $2,403 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 21 | $12,999 | $2,261 | 17.4% |
| 91035 | Monitoring and recording of esophageal function through a capsule attached to the esophagus wall | Facility | 2023 | 15 | 15 | $5,700 | $982.72 | 17.2% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 12 | 12 | $5,268 | $962.04 | 18.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 14 | 14 | $5,418 | $871.86 | 16.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 123 | 193 | $168,489 | $29,831 | 17.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 76 | 167 | $55,611 | $10,003 | 18.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 40 | 40 | $42,560 | $7,865 | 18.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 40 | 40 | $37,880 | $6,123 | 16.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $35,420 | $5,804 | 16.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 62 | 62 | $40,610 | $5,101 | 12.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 15 | 15 | $18,030 | $3,292 | 18.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 25 | 25 | $15,775 | $2,783 | 17.6% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2022 | 11 | 13 | $6,214 | $1,137 | 18.3% |
About Dr. Claudia Sanmiguel, M.D
Dr. Claudia Sanmiguel, M.D is a Gastroenterology healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/11/2008. The National Provider Identifier (NPI) number assigned to this provider is 1144474610.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Claudia Sanmiguel, M.D has received a total of $6,321 in payments from pharmaceutical and medical device companies, with $1,513 received in 2024. These payments were reported across 285 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,292).
As a Medicare-enrolled provider, Sanmiguel has provided services to 1,458 Medicare beneficiaries, totaling 1,899 services with total Medicare billing of $224,118. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Santa Monica, CA
- Active Since 11/11/2008
- Last Updated 09/14/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144474610
Products in Payments
- XIFAXAN (Drug) $1,074
- SKYRIZI (Biological) $538.28
- HUMIRA (Biological) $444.89
- LINZESS (Drug) $422.06
- RINVOQ (Biological) $408.59
- STELARA (Biological) $387.64
- ZEPOSIA (Drug) $274.76
- CREON (Drug) $268.03
- ZENPEP (Drug) $251.75
- Da Vinci Surgical System (Device) $193.03
- DIFICID (Drug) $167.06
- TRULANCE (Drug) $153.63
- VIBERZI (Drug) $125.26
- OCALIVA (Drug) $123.50
- ENTYVIO (Biological) $120.89
- OMVOH (Drug) $104.79
- ESOPHYX (Device) $102.64
- SUCRAID (Drug) $92.80
- DUPIXENT (Biological) $91.87
- TREMFYA (Drug) $81.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Santa Monica
Alireza Sedarat, Md, MD
Gastroenterology — Payments: $104,838
Marc Wishingrad, Md, MD
Gastroenterology — Payments: $24,677
Dr. Rudolph Bedford, M.d, M.D
Gastroenterology — Payments: $17,303
Dr. Lenna Martyak, M.d, M.D
Gastroenterology — Payments: $11,403
Dr. Kamyar Shahedi, M.d, M.D
Gastroenterology — Payments: $8,847
Charles Frankel, M.d, M.D
Gastroenterology — Payments: $4,737